- Exchange: Korea SE
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Kun Wha Pharmaceutical Co Ltd+ Add to Watchlist
002250:KS19,350 KRW 50 0.26%
As of 02:03:37 ET on 04/18/2014.
Company Profile for Kun Wha Pharmaceutical Co Ltd (002250)
Kun Wha Pharmaceutical Co., Ltd. is a pharmaceutical company. The Company researches, develops, manufactures, and markets drugs such as anti-inflammatory agents, antibiotics, antifungal agents, and remedies for the alimentary and cardiovascular systems.
Kun Wha Pharmaceutical Co Ltd
Key Executives for Kun Wha Pharmaceutical Co Ltd (002250)
|Lee Joo-HyungCEO/Rep Director||Wilhelm Robert VishwaExecutive Director|
|Divya PatelExecutive Director||Kevin Michael BainExecutive Director|
|Jin Seong-HoExecutive Director||Kim Yeong-HoExecutive Director|
|Lee Hong-UExecutive Director||Yun Chang-SeopExecutive Director|